Delivery Order SPE2DB24D9144-SPE2DB24FCMFU

Award Date 6/17/24
Potential Completion Date 6/18/24
Potential Value $8.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,311.35, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under a larger indefinite delivery contract (IDC) with DLA, valued at up to $499,999,999, that allows DLA to issue firm fixed-price orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of...
This federal contract award, valued at $12,508.77, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for the supply of the pharmaceutical product XTANDI 40 MG TABLET 120S, with a period of performance through April 17, 2024. This contract award is part of a larger $499,999,999 indefinite delivery contract (IDC)...
This federal contract award, valued at $25,868.10, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a delivery order under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the agency to place orders for a comprehensive range of pharmaceutical products to support the medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $8,339.18 delivery order is for the supply of XTANDI 80 MG TABLET 60S, a pharmaceutical product, and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price...
This federal contract award is for $4,311.35 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to supply XTANDI 40 MG CAPSULE 120S. The award is not associated with a set-aside program. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
This federal contract award, valued at $4,311.35, was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract is a delivery order under DMS Pharmaceutical Group's existing Indefinite Delivery Vehicle (IDV) contract SPE2DB, which has a ceiling value of up to $4,999,999 through the end of 2025. This IDV allows DLA to issue firm fixed-price...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,339.18 delivery order is for the supply of XTANDI 40 MG TABLET 120S, a specialized pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $8,643.00, is a firm fixed-price delivery order for the supply of 120 capsules of the prescription drug Xtandi 40 mg. The contract is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to...
This contract award, valued at $4,169.59, was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The award is a delivery order under the DLA's SPE2DB prime vendor program, which provides a comprehensive range of pharmaceutical items to military health facilities worldwide. Through this single-award indefinite delivery contract valued up to $499,999,999, DMS Pharmaceutical Group supplies a variety of branded...
  • SPE2DB24D9144
    Indefinite Delivery Contract
  • SPE2DB24D9144-SPE2DB24FCMFU
    Delivery Order

This federal contract award, valued at $8,339.18, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a delivery order under a larger indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999 that allows DLA to issue firm fixed-price orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. This IDC, which runs through December 31, 2025, complements DMS Pharmaceutical Group's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense (DoD) sites. The specific award is for the delivery of 60 tablets of the pharmaceutical product XTANDI 80 MG, with no set-aside designation. DMS Pharmaceutical Group is a key supplier of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to the DoD and Department of Veterans Affairs under various federal contract vehicles.

Generated 9/16/24, 10:34 AM